Where does Xencor, Inc. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Xencor, Inc. ranks #2,764 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Xencor, Inc. hold?

Xencor, Inc. holds 140 US utility patents granted between 2015 and 2025, spanning 10 technology areas.

What is Xencor, Inc.'s Innovation Score?

Xencor, Inc. has an Innovation Score of 44.6 out of 100 (top 25% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Xencor, Inc. focus on?

Xencor, Inc.'s top technology area is C07K (Peptides) with 140 patents. Grants appear in 10 CPC subclasses total.

Is Xencor, Inc.'s patent grant rate increasing or decreasing?

Xencor, Inc.'s recent grant velocity is +41% compared to the prior five-year period (grant years, not application filing dates). The company is maintaining or growing its granted-patent output.

What does claim depth mean for Xencor, Inc.'s patents?

Xencor, Inc.'s patents average 11.6 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Xencor, Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Xencor, Inc.

USPTO PatentsView assignee record - 140 granted patents across 10 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: C07K (Peptides).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Xencor ranks #2,764 of 49,997 tracked US assignees by granted-patent volume, with 140 patents across 10 technology areas.

#2,764
of 49,997 US assignees by volume: Top 25%
by Innovation Score (44.6/100): 11.6
avg claims per patent: +41%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R2764 · US Corporation #2,764 · 140 grants

GRANTS-MID · TOP-DECILE · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-PAR · TYPE-USCORP · VEL-UP · BOOK-FULL

GRANTS-MID 140 grants
TOP-DECILE #2,764/49,997
PHOTO-FINISH Landa
CPC-FOCUS C07K · 10 areas
INNOV-PAR 44.6/100
CLAIMS-PAR 11.6 claims/avg
TYPE-USCORP US Corporation
VEL-UP +41% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Landa Corporation Ltd. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

Qualcomm Incorporated · highest

85
Asmo · near

45
ATS Automation… · near

45
Extreme Networks · near

45
Xencor · this assignee

45
Duelight · near

45
3D Lighting… · lowest

7

What this shows Xencor's Innovation Score is 44.6/100 (top 25% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Where Xencor's grants concentrate

Xencor, Inc. is a focused PatentsView assignee: 10 CPC subclasses with 100% of grants classified under C07K (Peptides). Peak complete grant year is 2022 (22 grants) versus a trough of 7 in 2016. By volume, Xencor sits between Landa Corporation Ltd. and Cytiva Sweden AB.

Xencor's three-year grant acceleration

From 2019–2021 to 2022–2024, Xencor, Inc. moved from 37 to 52 grants (1.41x the prior three-year total, a multiple, not a CAGR). Among 3,296 tracked assignees with ≥100 grants and ≥20 prior-period grants, that multiple ranks #518. See the growth leaderboard.

Landa

140
Mattson Technology

140
Reald Spark

140
The United States…

140
Xencor ◀

140
Bar-ilan Universi…

139
Bardy Diagnostics

139
Beijing Institute…

139
Cytiva Sweden AB

139

What this shows Xencor holds 140 patents at rank #2,764, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Xencor

By rank, the assignees closest to #2,764 in granted patent volume.

Leaders in C07K (Peptides)

Other assignees with the most granted patents in Xencor's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Xencor, neither rank-band nor same-CPC leaders (those blocks stay above).

Similar innovation score

Nearest assignees by Innovation Score (45 here).

Asmo Co., Ltd. 45 Extreme Networks, Inc. 45 ATS Automation Tooling Systems Inc. 45 Duelight LLC 45

Similar claim depth

Nearest assignees by average claims per patent (11.6 here).

Freni Brembo S.P.A. 11.6 avg Furukawa Automotive Systems Inc. 11.6 avg Johnson Controls, Inc. 11.6 avg Aisin AW Co., Ltd. 11.6 avg

Xencor's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

45 Top 25% higher than 75% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Xencor, Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	10	7.1%
2016	7	5.0%
2017	15	10.7%
2018	9	6.4%
2019	13	9.3%
2020	14	10.0%
2021	10	7.1%
2022	22	15.7%
2023	15	10.7%
2024	15	10.7%
2025partial year	10	7.1%

Which technologies does Xencor, Inc. patent most?

C07K - Peptides 140

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 106

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 94

C12N - Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media 22

Y02A - Technologies FOR Adaptation TO Climate Change 4

C12P - Fermentation OR Enzyme-using Processes TO Synthesise A Desired Chemical Compound OR Composition OR TO Separate Optical Isomers From A Racemic Mixture 4

G16B - Bioinformatics, i.e. Information AND Communication Technology [ICT] Specially Adapted FOR Genetic OR Protein-related Data Processing IN Computational Molecular Biology 4

G16C - Computational CHEMISTRY; CHEMOINFORMATICS; Computational Materials Science 4

G01N - Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties 1

C07H - SUGARS; Derivatives THEREOF; NUCLEOSIDES; NUCLEOTIDES; Nucleic Acids 1

Top 10 of 10 technology areas

Where it ranks

Overall rank by patents

#2,764

of 49,997 tracked assignees

Innovation Score

44.6 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

What to do with this data

Xencor, Inc.'s patent record in context - here's where to go next.

Xencor, Inc.'s lead technology class is C07K (Peptides), 100% of its portfolio - see every assignee active in that class. Explore C07K
Ranked #2,764 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Xencor, Inc. against Landa Corporation Ltd., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 44.6/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.